Rhenman & Partners Asset Management AB - Q3 2020 holdings

$1.12 Billion is the total value of Rhenman & Partners Asset Management AB's 82 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 100.0% .

 Value Shares↓ Weighting
HAL ExitHALLIBURTON CO$0-8,299
-100.0%
-0.01%
NLOK ExitNORTONLIFELOCK INC$0-6,926
-100.0%
-0.02%
WFC ExitWELLS FARGO CO NEW$0-5,272
-100.0%
-0.02%
BUD ExitANHEUSER BUSCH INBEV SA/NVsponsored adr$0-2,806
-100.0%
-0.02%
PFE ExitPFIZER INC$0-4,508
-100.0%
-0.02%
DIS ExitDISNEY WALT CO$0-1,338
-100.0%
-0.02%
JPM ExitJPMORGAN CHASE & CO$0-1,723
-100.0%
-0.02%
JHG ExitJANUS HENDERSON GROUP PLC$0-8,645
-100.0%
-0.02%
IBM ExitINTERNATIONAL BUSINESS MACHS$0-1,587
-100.0%
-0.02%
XOM ExitEXXON MOBIL CORP$0-5,388
-100.0%
-0.03%
MNTA ExitMOMENTA PHARMACEUTICALS INC$0-120,000
-100.0%
-0.43%
OMCL ExitOMNICELL INC$0-60,000
-100.0%
-0.46%
AIMT ExitAIMMUNE THERAPEUTICS INC$0-285,000
-100.0%
-0.51%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-10-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
UNITEDHEALTH GROUP INC40Q3 20234.0%
BIOMARIN PHARMACEUTICAL INC40Q3 20235.0%
ALKERMES PLC40Q3 20233.3%
LILLY ELI & CO39Q3 20235.8%
CVS HEALTH CORP39Q3 20233.5%
INTRA-CELLULAR THERAPIES INC39Q3 20232.4%
EDWARDS LIFESCIENCES CORP39Q3 20231.7%
VERTEX PHARMACEUTICALS INC38Q3 20234.3%
REVANCE THERAPEUTICS INC38Q3 20230.9%
ABBVIE INC37Q3 20234.4%

View Rhenman & Partners Asset Management AB's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-14
13F-HR2024-02-13
13F-HR/A2023-11-13
13F-HR2023-11-09
13F-HR2023-08-11
13F-HR2023-05-12
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-12
13F-HR2022-05-13

View Rhenman & Partners Asset Management AB's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (1124652000.0 != 1124651000.0)

Export Rhenman & Partners Asset Management AB's holdings